Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement
Fujisawa, Japan and Dublin, Ireland, October 4, 2018 …
Announcement on starting preparation to become a company independent from Takeda
We are pleased to announce that Axcelead Drug …
Announcement of Start of Business Partnership between Axcelead and LAP&P for Modeling and Simulation of Drug Discovery
We are pleased to announce that Axcelead Drug …